Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 24-Month Period (ProgStar Report No. 17)
FAF may serve as a convenient monitoring tool and suitable end point for interventional clinical trials that aim to slow disease...
Professional(s) : Rupert STRAUSS, Isabelle Audo
Center(s) : Department of ophthalmology, Kepler University Clinic Linz, Linz, Austria ; RÉFÉRET National Hospital of Ophthalmology of Quinze-Vingts, Paris, France
Working group(s) : Retinal Rare Eye Diseases (WG1)